---
title: "Hepatitis B: Risks, Prevention, and Treatment"
slug: "hepatitis-b"
description: "A clear overview of hepatitis B, including symptoms, transmission, chronic disease risks, vaccination schedules, and treatment options."
category: "Infectious Diseases"
publishDate: "2025-09-04"
updatedDate: "2025-12-10"
tags: ["hepatitis B", "liver disease", "vaccination", "public health"]
draft: false
---

import JsonLd from "../../components/JsonLd.astro"
import StratBox from "../../components/StratBox.astro"

<JsonLd>
{JSON.stringify([
  {
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "name": "Hepatitis B: Risks, Prevention, and Treatment",
    "description": "Overview of hepatitis B, including transmission, symptoms, chronic complications, vaccination, diagnosis, and available treatments.",
    "mainEntityOfPage": {
      "@type": "WebPage",
      "@id": "https://patientguide.io/guides/hepatitis-b"
    },
    "about": {
      "@type": "MedicalCondition",
      "name": "Hepatitis B",
      "alternateName": "HBV infection",
      "description": "A viral infection of the liver that can cause acute or chronic disease. Chronic infection may lead to cirrhosis or liver cancer.",
      "cause": "Hepatitis B virus (HBV), usually transmitted via blood or bodily fluids.",
      "signOrSymptom": [
        "Fatigue",
        "Loss of appetite",
        "Nausea",
        "Vomiting",
        "Abdominal pain",
        "Dark urine",
        "Pale stools",
        "Jaundice"
      ],
      "possibleTreatment": [
        "Supportive care for acute infection",
        "Antiviral medications for chronic infection (e.g., tenofovir, entecavir)",
        "Liver transplant for advanced disease"
      ]
    }
  },
  {
    "@context": "https://schema.org",
    "@type": "FAQPage",
    "mainEntity": [
      {
        "@type": "Question",
        "name": "Is hepatitis B curable?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Chronic hepatitis B cannot usually be cured completely, but antiviral medicines can control the virus and reduce liver damage. Research into curative therapies continues."
        }
      },
      {
        "@type": "Question",
        "name": "Can you get hepatitis B more than once?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "People who clear natural infectionâ€”or complete the vaccine seriesâ€”typically develop long-lasting immunity."
        }
      },
      {
        "@type": "Question",
        "name": "Is the hepatitis B vaccine safe?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Yes. It has been used globally for decades and has an excellent safety profile."
        }
      },
      {
        "@type": "Question",
        "name": "Why is hepatitis B vaccination sometimes given at birth?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "A birth dose protects infants during the highest-risk period for lifelong chronic infection. Many health systems use it universally or for high-risk infants."
        }
      },
      {
        "@type": "Question",
        "name": "How common is hepatitis B today?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Globally, nearly 300 million people live with chronic hepatitis B, and many deaths each year are due to complications such as cirrhosis and liver cancer."
        }
      }
    ]
  }
])}
</JsonLd>

## Intro
Hepatitis B is a viral infection that attacks the liver and can cause both short-term (acute) and lifelong (chronic) illness. Around **300 million people worldwide** live with chronic hepatitis B, making it one of the major causes of cirrhosis and liver cancer globally.

Vaccinationâ€”especially in infancyâ€”is the most effective way to prevent infection.

If you want detailed guidance on the **Hepatitis B birth dose**, see:  
ðŸ‘‰ [/guides/hepatitis-b-birth-dose-explained](/guides/hepatitis-b-birth-dose-explained)

If you want analysis of new US policy changes, see:  
ðŸ‘‰ [/posts/cdc-hepb-birthdose-debate](/posts/cdc-hepb-birthdose-debate)

---

## Key Points
- Hepatitis B is transmitted through blood or bodily fluids.  
- Newborns and infants are at the highest risk of developing chronic infection.  
- Chronic HBV infection can lead to cirrhosis, liver failure, and liver cancer.  
- The **vaccine provides >95% long-term protection** when the full series is completed.  
- Many countries use a birth dose to protect infants immediately after birth.  
- Antiviral medicines control chronic infection but do not usually cure it.  

---

## Hepatitis B by the Numbers
- **~300 million** people worldwide live with chronic hepatitis B.  
- **Up to 90%** of newborns infected at birth develop chronic infection.  
- **>95%** vaccine effectiveness after completing the series.  
- Dramatic falls in childhood liver cancer in countries using universal infant vaccination.  
- Hepatitis B contributes to **hundreds of thousands of deaths** each year from liver disease.  

---

## Background
HBV is extremely infectiousâ€”more so than hepatitis C or HIV. It can survive on surfaces and in dried blood for days, making household transmission possible in early childhood.

Unlike hepatitis A, which is short-lived, hepatitis B can persist in the body for decades.

---

## Causes and Transmission
HBV is spread through:

- **Birth (mother-to-child)**  
- **Household exposure** (microscopic blood, shared grooming items)  
- **Sexual contact**  
- **Injection drug use**  
- **Medical procedures** using unsterile equipment  
- **Needlestick injuries**

Infants infected at or around birth face the highest risk of lifelong infection.

---

## Symptoms
Most acute infectionsâ€”especially in childrenâ€”cause few or no symptoms. When symptoms do occur, they may include:

- Fatigue  
- Nausea, vomiting  
- Loss of appetite  
- Fever  
- Abdominal discomfort  
- Dark urine, pale stools  
- Jaundice (yellow eyes/skin)

Chronic hepatitis B is often silent until severe liver damage emerges.

---

## Diagnosis
HBV is diagnosed and monitored through:

- **HBsAg** (surface antigen)  
- **Anti-HBs** (surface antibody)  
- **Anti-HBc** (core antibody)  
- **HBV DNA** (viral load)  
- Liver function tests  
- Ultrasound or elastography for fibrosis  
- Liver cancer surveillance in high-risk patients

---

## Treatment

### Acute hepatitis B
- Most healthy adults clear the virus naturally.  
- Treatment is usually supportive.  

### Chronic hepatitis B
Aimed at reducing liver damage:

- **Antiviral medicines** (tenofovir, entecavir)  
- Regular liver monitoring  
- Cancer screening in higher-risk individuals  
- **Liver transplant** for advanced cirrhosis  

A complete cure is still being researched, but new therapies are in development.

---

## Prevention

### Vaccination
The safest and most effective strategy.

**Infants:**  
- Many systems give a **birth dose**, then doses at 2, 4, and 6 months.  
- Others begin at 6â€“8 weeks for low-risk infants.

For full birth-dose details, see:  
ðŸ‘‰ **Hepatitis B Birth Dose Guide** (/guides/hepatitis-b-birth-dose-explained)

**Adults & adolescents:**  
- Two- or three-dose catch-up options  
- Strongly recommended for healthcare workers, people who inject drugs, and other high-risk groups

### Other strategies
- Screening pregnant women  
- Antiviral therapy in pregnant women with high viral load  
- Safe sex practices and condom use  
- Testing and vaccination of household contacts  
- Avoiding shared razors, toothbrushes  
- Needle and syringe programs  

---

## Recent Developments
- WHO aims to **eliminate hepatitis B as a public health threat by 2030**.  
- Debate has emerged around changes to the **US birth-dose policy**.  
  See the analysis here:  
  ðŸ‘‰ [/posts/cdc-hepb-birthdose-debate](/posts/cdc-hepb-birthdose-debate)
- Multiple curative therapies are in clinical trials, including capsid inhibitors, siRNA therapies, therapeutic vaccines, and immune modulators.

---

## FAQ

**Is hepatitis B curable?**  
Not usually. Chronic infection can be controlled with antiviral medicines.

**Can hepatitis B come back after vaccination?**  
Breakthrough infection is extremely rare. The vaccine provides long-term immunity for most people.

**Why do some countries give a birth dose?**  
To prevent early-life infection and provide a safety net when testing fails.

**How dangerous is chronic hepatitis B?**  
Very. It significantly increases the risk of cirrhosis and liver cancer.

**Do I need testing if I was vaccinated?**  
Most people do not, but certain high-risk groups (e.g., healthcare workers) may require titres.

---

## Further Reading
- [/guides/hepatitis-b-birth-dose-explained](/guides/hepatitis-b-birth-dose-explained)  
- [CDC Hepatitis B](https://www.cdc.gov/hepatitis/hbv/)  
- [WHO Hepatitis B](https://www.who.int/)  
- [Hepatitis B Foundation](https://www.hepb.org/)

---

## Related Guides
- [/guides/hepatitis-b-birth-dose-explained](/guides/hepatitis-b-birth-dose-explained)  
- [/guides/liver-cancer](/guides/liver-cancer)  
- [/guides/infectious-diseases](/guides/infectious-diseases)
